A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Deficiencia de proteína S; Deficiencia de proteína C
Los fármacos anticoagulantes (heparina y warfarina) se utilizan para tratar y prevenir coágulos de sangre.
El pronóstico usualmente es bueno con tratamiento, pero los síntomas pueden reaparecer.
En raras ocasiones, el hecho de utilizar warfarina para licuar la sangre y prevenir coágulos puede causar un breve incremento en la coagulación y lesiones cutáneas severas. Los pacientes están en riesgo si no reciben tratamiento con el anticoagulante heparina antes de tomar warfarina.
Consulte con el médico si tiene síntomas de coagulación en una vena, como hinchazón y enrojecimiento de la pierna.
Schafer AI. Thrombotic disorders: hypercoagulable states. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 182.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.800.492.5538